ArchivesJohn Walker2023-02-27T20:11:47-08:00

Archives

905, 2024

Prometheus Laboratories Announces New Health Plan Agreements to Provide Precision-Guided Testing Services

Judy Gohndrone2024-05-09T10:00:08-07:002024-05-09|

News & Events Prometheus [...]

2112, 2023

Prometheus Laboratories Announces a Major Milestone in Demonstrating Clinical Utility of Precision-Guided Dosing for Optimizing IBD Patient Care and Cost Savings

John Walker2023-12-21T06:05:00-08:002023-12-21|

News & Events Prometheus [...]

2908, 2023

Prometheus Laboratories Surpasses 35 Million Covered Lives Under Positive Medical Policy for Anser® Therapeutic Drug Monitoring

John Walker2024-03-13T11:47:03-07:002023-08-29|

News & Events Prometheus [...]

108, 2023

Prometheus Laboratories Announces Collaboration with Fresenius Kabi on Anser® Testing

John Walker2024-03-13T11:46:12-07:002023-08-01|

News & Events Prometheus [...]

2707, 2023

Prometheus Laboratories Announces the Launch of PredictrPK® ADA, A Precision-Guided Dosing Test for Optimization of Adalimumab

John Walker2023-07-26T15:59:06-07:002023-07-27|

News & Events Prometheus [...]

205, 2023

Lynx.MD Partners with Prometheus Laboratories and Gastro Health to Leverage Medical Data Intelligence Platform for Inflammatory Bowel Disease Research

John Walker2023-07-18T16:09:33-07:002023-05-02|

News & Events Lynx.MD [...]

Previous 123 Next